I

ImmunoVaccine Technologies

6 employees

IMV Inc applies its novel platform to the development of vaccines for cancer therapy, infectious diseases, and animal health.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Diagnostics
Therapeutics

Date founded

2000

Funding rounds raised

Total raised

$25M

from 3 investors over 3 rounds

I

ImmunoVaccine Technologies raised $25M on December 20, 2021

Investors: Horizon Technology Finance

I

ImmunoVaccine Technologies raised $18M on May 7, 2020

Investors: Altium Capital and Lumira Ventures

FAQ